{"id":"W2142739119","doi":"10.1093/jnci/dji250","title":"Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1120,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Letrozole; Medicine; Hazard ratio; Breast cancer; Tamoxifen; Internal medicine; Interim analysis; Adjuvant therapy; Oncology; Aromatase inhibitor; Placebo; Clinical endpoint; Proportional hazards model; Surgery; Gynecology; Cancer; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677997,0.0007254701,0.002857788,0.0007713075,0.0002491297,0.001110423,0.0006643878,0.001462823,0.003854367],"category_scores_gemma":[0.007204537,0.000304848,0.00209786,0.0008309773,0.0003977625,0.000549365,0.0003987998,0.001709266,0.0003911233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007847124,"about_ca_system_score_gemma":0.001793858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001720757,"about_ca_topic_score_gemma":0.005150734,"domain_scores_codex":[0.9973575,0.002056031,0.0001760414,0.0001222318,0.0001860704,0.0001019742],"domain_scores_gemma":[0.9969157,0.001386075,0.0009848056,0.0001445959,0.0002023745,0.000366346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.919926,0.001099915,0.001772524,0.003916658,0.007023952,0.0001454866,0.00006088044,0.0005164425,0.001771243,0.0003295651,0.004250614,0.05918662],"study_design_scores_gemma":[0.958586,0.02033442,0.005532246,0.0006196991,0.008875592,0.0001141102,0.00002226322,0.0003158885,0.000239346,0.0002388587,0.005097475,0.0000239222],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7342619,0.2238239,0.001878154,0.009753046,0.005340272,0.009732195,0.006773452,0.0002363096,0.008200705],"genre_scores_gemma":[0.9139347,0.05011302,0.003904615,0.008193175,0.003264887,0.009531745,0.005410212,0.0000567661,0.005590901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003854367,"threshold_uncertainty_score":0.01945132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01683296835497545,"score_gpt":0.3131470373556251,"score_spread":0.2963140690006497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}